These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36351361)

  • 1. Antibiotics, the microbiome and gastrointestinal cancers: A causal interference?
    Ramai D; Salati M; Pomati G; Amoroso C; Facciorusso A; Botticelli A; Ghidini M
    Curr Opin Pharmacol; 2022 Dec; 67():102315. PubMed ID: 36351361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Gut Microbiota and Gastrointestinal Cancer.
    Meng C; Bai C; Brown TD; Hood LE; Tian Q
    Genomics Proteomics Bioinformatics; 2018 Feb; 16(1):33-49. PubMed ID: 29474889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiome in gastrointestinal cancer: a friend or foe?
    Liu Y; Baba Y; Ishimoto T; Gu X; Zhang J; Nomoto D; Okadome K; Baba H; Qiu P
    Int J Biol Sci; 2022; 18(10):4101-4117. PubMed ID: 35844804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the microbiome in drug resistance in gastrointestinal cancers.
    Garajová I; Balsano R; Wang H; Leonardi F; Giovannetti E; Deng D; Peters GJ
    Expert Rev Anticancer Ther; 2021 Feb; 21(2):165-176. PubMed ID: 33115280
    [No Abstract]   [Full Text] [Related]  

  • 5. The gastrointestinal microbiota and its role in oncogenesis.
    Lam SY; Yu J; Wong SH; Peppelenbosch MP; Fuhler GM
    Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):607-618. PubMed ID: 29566903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the gut microbiome in gastrointestinal cancers.
    Mishra Y; Ranjan A; Mishra V; Chattaraj A; Aljabali AAA; El-Tanani M; Hromić-Jahjefendić A; Uversky VN; Tambuwala MM
    Cell Signal; 2024 Mar; 115():111013. PubMed ID: 38113978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota and gastrointestinal cancer.
    Weng MT; Chiu YT; Wei PY; Chiang CW; Fang HL; Wei SC
    J Formos Med Assoc; 2019 Mar; 118 Suppl 1():S32-S41. PubMed ID: 30655033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?
    Smet A; Kupcinskas J; Link A; Hold GL; Bornschein J
    Cell Mol Gastroenterol Hepatol; 2022; 13(3):857-874. PubMed ID: 34506954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic perturbations to the gut microbiome.
    Fishbein SRS; Mahmud B; Dantas G
    Nat Rev Microbiol; 2023 Dec; 21(12):772-788. PubMed ID: 37491458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiome and Gastrointestinal Cancer: Les liaisons Dangereuses.
    Tözün N; Vardareli E
    J Clin Gastroenterol; 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015():S191-S196. PubMed ID: 27741173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THE EFFECTS OF ANTIBIOTICS ON THE GUT MICROBIOME AND THE IMMUNE SYSTEM (Review).
    Nurgaziyev M; Sergazy S; Chulenbayeva L; Nurgozhina A; Gulyayev A; Kozhakhmetov S; Kartbayeva G; Kushugulova A
    Georgian Med News; 2020 Jun; (303):167-173. PubMed ID: 32841200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of modulating the gastrointestinal microbiota in cancer patients.
    Morkūnas E; Skiecevičienė J; Kupčinskas J
    Best Pract Res Clin Gastroenterol; 2020; 48-49():101700. PubMed ID: 33317795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the cross-talk between human microbiota and gastrointestinal cancer for developing potential diagnostic and prognostic biomarkers.
    Kashyap S; Pal S; Chandan G; Saini V; Chakrabarti S; Saini NK; Mittal A; Thakur VK; Saini AK; Saini RV
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):643-651. PubMed ID: 33971261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-bacteria microbiome (virus, fungi, and archaea) in gastrointestinal cancer.
    Coker OO
    J Gastroenterol Hepatol; 2022 Feb; 37(2):256-262. PubMed ID: 34825404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances.
    Peng C; Ouyang Y; Lu N; Li N
    Front Immunol; 2020; 11():1387. PubMed ID: 32695120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut microbiota in internal medicine: implications for health and disease.
    Lankelma JM; Nieuwdorp M; de Vos WM; Wiersinga WJ
    Neth J Med; 2015 Feb; 73(2):61-8. PubMed ID: 25753070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The implication of gut microbiota in recovery from gastrointestinal surgery.
    Zheng Z; Hu Y; Tang J; Xu W; Zhu W; Zhang W
    Front Cell Infect Microbiol; 2023; 13():1110787. PubMed ID: 36926517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotics and the developing infant gut microbiota and resistome.
    Gibson MK; Crofts TS; Dantas G
    Curr Opin Microbiol; 2015 Oct; 27():51-6. PubMed ID: 26241507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiome analysis as a predictive marker for the gastric cancer patients.
    Zhang Y; Shen J; Shi X; Du Y; Niu Y; Jin G; Wang Z; Lyu J
    Appl Microbiol Biotechnol; 2021 Jan; 105(2):803-814. PubMed ID: 33404833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging frontiers of antibiotics use and their impacts on the human gut microbiome.
    Kumari R; Yadav Y; Misra R; Das U; Das Adhikari U; Malakar P; Dubey GP
    Microbiol Res; 2022 Oct; 263():127127. PubMed ID: 35914416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.